230. Alveolar hypoventilation syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 6 / Drugs : 7 - (DrugBank : 4) / Drug target genes : 16 - Drug target pathways : 26
Alveolar hypoventilation syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 230 | Alveolar hypoventilation syndrome |
| 13 | Multiple sclerosis/Neuromyelitis optica |
| 86 | Pulmonary arterial hypertension |
| 115 | Hereditary periodic paralysis |
| 154 | Epilepsy with continuous spikes and waves during slow sleep |
| 114 | Non-dystrophic myotonia syndrome |
| 90 | Retinitis pigmentosa |
| 155 | Acquired aphasia with convulsive disorder |
| 225 | Congenital nephrogenic diabetes insipidus |
| 6 | Parkinson disease |